Analysis | By Eric Wicklund | December 16, 2021
A partnership between a telehealth company specializing in mental healthcare and a biotech company will use remote patient monitoring to monitor patients with mental healthcare needs and develop n
888-776-0942 from 8 AM - 10 PM ET
Strategic funding will support company's growth and global expansion of continuous multi-parameter monitoring devices and data services for medical grade remote care at scale
DENVER , July 28, 2021 /PRNewswire/ -- BioIntelliSense, Inc., a
The Independent Liverpool Student Newspaper
The report published by In4Research on Cleats Shoes Market is the most reliable information source as the study relies on a specific research methodology that focuses on both primary and secondary sources. The primary source, including intervie
NASHUA, N.H.--(BUSINESS WIRE )--BraveHeart Wireless Inc today announced a strategic agreement with Analog Devices, Inc. to collaborate on a complete, end-to-end remote patient monitoring (RPM) system. BraveHeart, a startup based in Nashua, NH, and Analog Devices will work together to incorpor
888-776-0942 from 8 AM - 10 PM ET
NILES, Ill. , Oct. 26, 2021 /PRNewswire/ -- Sibel Health, an award-winning medical technology company spun out of the Querrey Simpson Institute for Bioelectronics at Northwestern University , announced its first 510(k) clearance from the U.S. Fo
DGAP-News: G Medical Innovations Holdings 01.12.2021 / 13:15 The issuer is solely responsible for the content of this announcement.
G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clini
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
LifeSignals today announced that it has received FDA 510(k) clearance for its LX1550 multi-parameter remote monitoring platform.
Fremont, Calif.–based LifeSignals designed the LX1550 to continuously collect patient physiological data from home and in healthcare settings.
The plat
The global blood glucose monitoring market size was estimated to be USD 13.95 billion in 2021 and reach USD 23.01 billion in 2027, which is expected to register a CAGR of 8.7% during the forecast period, 2021-2027. Blood glucose monitoring devices are economically beneficial and extensive
United States Blood Glucose Monitoring Devices Market, By Product (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices), By Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital & Clinics, Others), By Region,